Oncolytic adenovirus

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7078030
SERIAL NO

10733674

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Viral vectors and methods of making such vectors are described that preferentially kill neoplastic but not normal cells, the preferred vector being an adenovirus that has the endogenous promoters in the E1A and/or E4 regions substituted with a tumor specific promoter which is preferably E2F responsive.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ONYX PHARMACEUTICALS INCONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fattaey, Ali Oakland, CA 16 136
Hermiston, Terry Corte Madera, CA 52 309
Johnson, Leisa Richmond, CA 10 156
Laquerre, Sylvie Conshohocken, PA 45 146
Shen, Jerry Yuqiao Orinda, CA 2 13

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation